Class Action Lawsuit Filed Against ModivCare, Inc. (MODV): What You Need to Know Before the March 31, 2025 Deadline to Join

Important Information for ModivCare Investors: Securities Class Action Lawsuit Announced

New York, NY, Feb. 25, 2025 – In a significant development for investors of ModivCare Inc. (“ModivCare” or the “Company”) (NASDAQ: MODV), Levi & Korsinsky, LLP has announced the filing of a securities class action lawsuit. The lawsuit alleges that ModivCare and certain of its top executives violated the Securities Exchange Act of 1934 between November 3, 2022, and September 15, 2024.

Class Definition

The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by the alleged securities fraud. The class definition includes all persons or entities who purchased or otherwise acquired ModivCare securities between November 3, 2022, and September 15, 2024.

Impact on Individual Investors

If you invested in ModivCare during the specified period and suffered financial losses, you may be eligible to recover your damages. As a ModivCare investor, you may have relied on the Company’s misrepresentations or omissions about its business, operations, and financial condition. By filing this lawsuit, the plaintiffs aim to hold the Company and its executives accountable for any financial harm caused to investors.

Global Implications

The securities lawsuit against ModivCare has far-reaching implications for the global investment community. It underscores the importance of transparency and honesty in corporate reporting. When companies and their executives fail to disclose material information, it can create a ripple effect that impacts not only individual investors but also the broader financial markets.

Moreover, the lawsuit serves as a reminder that investors have legal recourse when they suffer losses due to securities fraud. Class action lawsuits like this one can help deter similar behavior in the future and promote a more level playing field for all investors.

Next Steps for ModivCare Investors

If you invested in ModivCare during the specified period and wish to learn more about the securities class action lawsuit, we encourage you to contact Levi & Korsinsky, LLP. The firm can provide you with additional information about your rights and potential remedies.

  • Contact Levi & Korsinsky, LLP: 800-315-0345 or 212-363-7576
  • Email: [email protected]
  • Visit: https://www.zlk.com/modv

Conclusion

The securities class action lawsuit against ModivCare is a significant development for investors who purchased the Company’s securities between November 3, 2022, and September 15, 2024. The lawsuit alleges securities fraud, and if successful, could result in financial damages for affected investors. This case underscores the importance of transparency and honesty in corporate reporting and the legal remedies available to investors when they are harmed by securities fraud.

As a responsible investor, it is crucial to stay informed about any developments that may impact your investments. We encourage all ModivCare investors to contact Levi & Korsinsky, LLP for more information about their potential rights and remedies. By working together, we can help promote accountability and transparency in the financial markets.

Levi & Korsinsky, LLP is a national law firm with offices in New York, California, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation and has recovered significant damages for aggrieved investors. For more information, please visit www.zlk.com.

Leave a Reply